Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro reduces appetite significantly, but it does not neutralise the effect of what you eat. Trial data from SURMOUNT-1, published in the New England Journal of Medicine, showed average weight reductions of around 20–21% at the highest dose — but participants followed a reduced-calorie diet alongside the injections. Tirzepatide is a prescription-only medicine; a prescriber decides whether it is clinically appropriate for you, and part of that assessment covers the lifestyle changes expected alongside it. So no, eating whatever you like will not give you the results the trials demonstrated — and here is why that matters.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 results (around 20% average body-weight reduction over 72 weeks at 15 mg) came from a trial in which participants followed a 500 kcal/day deficit diet and increased their physical activity. Tirzepatide was not tested in a free-for-all eating context. That is not a small footnote; it is built into the licence. The NHS medicines page for tirzepatide is explicit: treatment is indicated alongside a reduced-calorie diet and increased physical activity. The medicine does the heavy lifting on appetite, but the dietary structure is part of the mechanism, the two work together.
What tirzepatide changes is your internal experience of hunger. Its dual action on GIP and GLP-1 receptors slows how quickly the stomach empties and strengthens the signals your gut sends to tell the brain you are full. The practical result for most people is that meals feel satisfying on smaller portions, cravings lose their urgency, and the idea of a second helping simply stops being appealing. That shift makes eating less feel manageable rather than punishing. It does not, though, make a bag of crisps suddenly low in calories.
If you want to understand what to eat on Mounjaro in practical terms, the short answer is foods that are dense in protein and fibre, low in saturated fat, and unlikely to trigger nausea. For a closer look at what you can eat on Mounjaro day to day, including which everyday choices tend to work well alongside the medicine, that guide walks through the options in plain terms.
Gastric emptying slows on tirzepatide. That is useful for appetite, but it means that heavy, fatty or very rich meals sit in the stomach longer than usual and are far more likely to cause nausea, reflux, or bloating. Think: a large fried breakfast, cream-heavy pasta, a greasy takeaway. These are the meals people report regretting most in the first few months of treatment.
Carbonated drinks compound the issue, the gas has nowhere to go quickly, and burping becomes uncomfortable. Alcohol deserves a mention too: tirzepatide does not have a dangerous interaction with alcohol, but appetite suppression can mask how much you have had, and alcohol adds empty calories that work against the reduced-calorie framework the treatment depends on.
There is a practical guide to foods to avoid on Mounjaro if you want a fuller breakdown. And if a specific food is on your mind (bread, for instance) the honest answer is usually that occasional portions are fine, but the overall dietary pattern is what shapes results.
Appetite suppression has a hidden risk: it is easy to eat so little that protein intake falls below what the body needs to preserve lean muscle. When you lose weight quickly without adequate protein, a larger share of that loss comes from muscle rather than fat. Muscle matters for metabolic rate, strength and long-term weight maintenance, losing it makes keeping weight off harder once treatment ends.
Most guidelines for people on GLP-1 medicines suggest aiming for at least 1.2 g of protein per kilogram of body weight daily. The practical challenge is hitting that target when you are not particularly hungry. A habit that helps: eating the protein component of a meal first, before appetite disappears mid-plate. Keep something quick in the fridge door (cooked chicken, Greek yoghurt, a boiled egg) for the moments when you know you should eat but do not feel like cooking.
If you are curious about specific foods and protein sources (peanuts, for example) they can contribute usefully to protein and healthy-fat intake in small amounts. Portion awareness still applies.
Thinking of tirzepatide as something that lets you sidestep dietary choices is a misreading of how it works, and of what the trial evidence actually shows. It is a powerful clinical tool for people who meet the prescribing criteria (adults with a BMI of 30 or above, or 27 and above with a weight-related health condition), but it works most effectively when diet and activity change alongside it. The NICE appraisal of tirzepatide (TA1026) was built on a body of evidence that included lifestyle support as standard.
That said, the appetite changes are real and often substantial. Many people find that they naturally start eating less processed food, not because they have resolved to, but because their body stops demanding it. The medicine creates conditions in which better habits become easier to build. That is different from those habits being unnecessary.
For a fuller look at how tirzepatide works and what the treatment involves, our Mounjaro overview covers the clinical picture end to end. If you are weighing up whether this treatment fits your situation, you can also explore our weight-loss treatment options before deciding what to do next.
Mounjaro is a prescription-only medicine. Whether it is right for you (and what dietary approach to follow alongside it) is a clinical decision. If you would like a prescriber to review your situation, start your free consultation and our team will go from there.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.